[New antihypertensive drugs on various phases of study].
Department of Internal Medicine, National Cardiovascular Center.
M
M
Kuramochi
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000596:Amino Acids / Q000494:pharmacology*; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D000959:Antihypertensive Agents; D009320:Atrial Natriuretic Factor / Q000037:antagonists & inhibitors; D001713:Biphenyl Compounds / Q000494:pharmacology; D004232:Diuretics / Q000494:pharmacology*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D019808:Losartan; D010456:Peptides, Cyclic / Q000494:pharmacology; D011956:Receptors, Cell Surface / Q000037:antagonists & inhibitors; D017466:Receptors, Endothelin; D013438:Sulfhydryl Compounds / Q000494:pharmacology*; D013777:Tetrazoles / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000596:Amino Acids; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D004232:Diuretics; D007093:Imidazoles; D010456:Peptides, Cyclic; D011956:Receptors, Cell Surface; D017466:Receptors, Endothelin; D013438:Sulfhydryl Compounds; D013777:Tetrazoles; D000804:Angiotensin II; C060193:SQ 29072; D009320:Atrial Natriuretic Factor; D019808:Losartan; C072247:cyclo(Trp-Asp-Pro-Val-Leu)